Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | adenosine deaminase | 0.0375 | 0.1341 | 0.5 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.1164 | 1 | 1 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.1164 | 1 | 1 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.1164 | 1 | 1 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0375 | 0.1341 | 0.5 |
Plasmodium vivax | adenosine deaminase, putative | 0.0375 | 0.1341 | 0.5 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0375 | 0.1341 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1164 | 1 | 1 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.1164 | 1 | 1 |
Leishmania major | adenine aminohydrolase | 0.0375 | 0.1341 | 0.5 |
Loa Loa (eye worm) | norepinephrine transporter | 0.1164 | 1 | 1 |
Mycobacterium ulcerans | adenosine deaminase | 0.0375 | 0.1341 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1164 | 1 | 1 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.0375 | 0.1341 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1164 | 1 | 1 |
Onchocerca volvulus | 0.1164 | 1 | 1 | |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0375 | 0.1341 | 0.5 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0375 | 0.1341 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0375 | 0.1341 | 0.1341 |
Echinococcus multilocularis | serotonin transporter | 0.1164 | 1 | 1 |
Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.0375 | 0.1341 | 0.5 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0375 | 0.1341 | 0.5 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0375 | 0.1341 | 0.5 |
Loa Loa (eye worm) | serotonin transporter b | 0.1164 | 1 | 1 |
Echinococcus granulosus | serotonin transporter | 0.1164 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.